Popular Candela Hair Removal Laser, GentleLASE, Proves Effective in Treating Leg Veins
WAYLAND, MASS. (April 19) BW HEALTHWIRE -April 19, 1999-- Laser's Dynamic Cooling Device(tm) Seen as Key to Clearing Large
Leg Veins, Company's ScleroPLUS(tm) Touted as Laser of
Choice for Smaller Veins
One of the country's leading dermatologists, Arielle N.B. Kauvar, M.D., reported at the American Society of Laser Medicine and Surgery's annual meeting (April 15-18, Orlando, FL) that Candela Corporation's (Nasdaq:CLZR) popular hair removal laser, the GentleLASE(tm), and the company's ScleroPLUS laser system, together, can safely and effectively treat unsightly leg veins, both large and small. This condition affects some 80 million men and women in the United States.
Dr. Kauvar reported on the results of a study, conducted at the Laser & Skin Surgery Center of New York, in which both a GentleLASE and ScleroPLUS were used to treat leg veins. Kauvar indicated that the GentleLASE, a long-pulse alexandrite laser, was particularly effective in treating large leg veins, while the ScleroPLUS, a pulsed-dye laser, was more effective in treating smaller veins.
Both lasers were equipped with Candela's Dynamic Cooling Device (DCD), which Kauvar cited as a major factor in the lasers' ability to produce improved clearance with fewer side effects. The DCD selectively cools the upper layers of the skin an instant before applying the laser energy, minimizing pain and thermal injury to the epidermis.
In the study, nineteen subjects were treated with the GentleLASE. Three months after just a single treatment, 75 percent of the subjects demonstrated greater than 75 percent clearing of leg veins, and all subjects showed greater than 50 percent clearance.
Results with the ScleroPLUS were equally positive, reported Kauvar. Again, nineteen patients were treated. Three months after just one treatment, 83 percent of the patients showed greater than 75 percent clearance of their leg veins, and all patients showed greater than 50 percent clearance.
Kauvar stated: "This study shows that by using these two laser systems, physicians can provide their patients with an effective, yet non-invasive approach for treating both small red, and larger purple or blue spider veins. The key is the Dynamic Cooling Device, which along with enabling the physician to deliver more comfortable treatment, permits, for the first time, the safe delivery of high energy, more deeply, without risk to collateral tissue." About Candela
Candela Corporation develops, manufactures, and distributes innovative clinical solutions that enable physicians, surgeons and personal care practitioners to treat selected cosmetic and medical conditions using lasers, cryosurgery and other proven technologies. Founded near Boston in 1970, Candela markets and services its products in over 40 countries from offices in the United States, Europe and Asia. Candela established the aesthetic laser market 11 years ago. With an installed base of over 2,000 lasers worldwide, more than 500,000 aesthetic laser procedures are performed annually with Candela laser systems. For more information about Candela, visit the company's web site at http://www.clzr.com.
This press release includes certain forward-looking statements. Any such statements are subject to risks that could cause the actual results to vary materially, including negative developments relating to unforeseen order cancellations or push-outs, Candela's strategic relationships, the impact of intense competition and changes in the laser industry.
-0- mb/bos*
CONTACT: Candela Marketing
Jane Smith, Candela Corporation, 508-358-7400, x247
or
Candela Public Relations
Richard Adler, Dimond Communications Group, 617-424-8373
or
Laser & Skin Surgery Center of NY
Lisa King, Ned Steele Communications, 212-243-8383
KEYWORD: MASSACHUSETTS
INDUSTRY KEYWORD: BIOTECHNOLOGY MEDICINE Today's News On The Net -
Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: http://www.businesswire.com